GSK Cash on Hand 2010-2022 | GSK

GSK cash on hand from 2010 to 2022. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • GSK cash on hand for the quarter ending September 30, 2022 was $8.689B, a 69.93% increase year-over-year.
  • GSK cash on hand for 2021 was $6.22B, a 25.73% decline from 2020.
  • GSK cash on hand for 2020 was $8.374B, a 25.95% increase from 2019.
  • GSK cash on hand for 2019 was $6.649B, a 20.14% increase from 2018.
GSK Annual Cash on Hand
(Millions of US $)
2021 $6,220
2020 $8,374
2019 $6,649
2018 $5,534
2017 $5,128
2016 $6,969
2015 $9,220
2014 $7,504
2013 $9,005
2012 $6,838
2011 $9,463
2010 $9,650
2009 $10,668
GSK Quarterly Cash on Hand
(Millions of US $)
2022-09-30 $8,689
2022-06-30 $8,333
2022-03-31 $18,991
2021-12-31 $6,220
2021-09-30 $5,113
2021-06-30 $5,124
2021-03-31 $6,965
2020-12-31 $8,374
2020-09-30 $5,906
2020-06-30 $10,764
2020-03-31 $7,810
2019-12-31 $6,649
2019-09-30 $6,053
2019-06-30 $5,680
2019-03-31 $5,675
2018-12-31 $5,534
2018-09-30 $5,119
2018-06-30 $5,733
2018-03-31 $5,889
2017-12-31 $5,128
2017-09-30 $6,530
2017-06-30 $5,289
2017-03-31 $5,848
2016-09-30 $6,373
2016-06-30 $7,563
2016-03-31 $6,630
2015-12-31 $9,220
2015-09-30 $9,453
2015-06-30 $11,801
2015-03-31 $15,866
2014-12-31 $7,504
2014-09-30 $7,326
2014-06-30 $5,588
2014-03-31 $6,070
2013-12-31 $9,005
2013-09-30 $5,385
2013-06-30 $4,713
2013-03-31 $6,431
2012-12-31 $6,838
2012-09-30 $5,833
2012-06-30 $12,024
2012-03-31 $9,173
2011-12-31 $9,463
2011-09-30 $8,898
2011-06-30 $10,011
2011-03-31 $10,675
2010-12-31 $9,650
2010-09-30 $9,988
2010-06-30 $10,143
2010-03-31 $11,270
2009-12-31 $10,668
2009-09-30 $11,066
2009-06-30 $8,726
2009-03-31 $9,840
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $69.125B $46.910B
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $168.477B 10.28
Bio-Rad Laboratories (BIO.B) United States $11.666B 27.68
QIAGEN (QGEN) Netherlands $11.120B 18.98
Ginkgo Bioworks Holdings (DNA) United States $3.552B 0.00
Myovant Sciences (MYOV) United Kingdom $2.592B 0.00
Arcus Biosciences (RCUS) United States $1.934B 29.03
Biohaven (BHVN) United States $1.080B 0.00
Emergent Biosolutions (EBS) United States $0.594B 4.67
Zymeworks (ZYME) Canada $0.494B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.276B 0.00
Enzo Biochem (ENZ) United States $0.095B 0.00
SQZ Biotechnologies (SQZ) United States $0.078B 0.00
Gelesis Holdings (GLS) United States $0.028B 0.00
Ambrx Biopharma (AMAM) United States $0.019B 0.00